Woodline Partners »

Sp Plus shares owned by Woodline Partners

Quarter-by-quarter ownership of Sp Plus shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Sp Plus

Tip: Access up to 7 years of quarterly data

All positions including Sp Plus held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sp Plus by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 260k 52.22

More positions owned by Woodline Partners

Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Encana Corporation (OVV)
Te Connectivity SHS (TEL)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Chord Energy Corporation Com New (CHRD)
Meta Platforms Cl A (META)
Marsh & McLennan Companies (MMC)
Permian Resources Corp Class A Com (PR)
Quest Diagnostics Incorporated (DGX)
Civitas Resources Com New (CIVI)
Electronic Arts (EA)
Progressive Corporation (PGR)
Zimmer Holdings (ZBH)

View all positions for Woodline Partners

Top funds holding Sp Plus

Magnetar Financial
Grantham, Mayo, Van Otterloo & Co
Absolute Gestao de Investimentos
Northern Trust
Mill Road Capital Management
Yakira Capital Management
Carmignac Gestion
Uniplan Investment Counsel
UBS Group
HighVista Strategies
Crabel Capital Management
Walleye Trading
Springbok Capital Management
Alberta Investment Management Corporation
Vestcor Investment Management Corp

View all funds holding Sp Plus